Press release
Hematuria Treatment Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Johnson & Johnson, Cipla Ltd, Pfizer Inc., Aurobindo Pharma USA, Zambon USA Ltd., GlaxoSmithKline plc
Hematuria Treatment Market - DataM Intelligence
Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/hematuria-treatment-market?sg
Industry Recent Developments 2025:
✅ 12 Jun 2025 - FDA approves UroGen's intravesical mitomycin product ZUSDURI (first FDA-approved mitomycin intravesical solution for recurrent low-grade, intermediate-risk NMIBC).
✅ 27 Feb 2025 - AUA/SUFU publishes the 2025 Microhematuria Guideline Amendment (refines risk stratification and, for the first time, permits use of validated urine-based tumor markers in appropriately counseled intermediate-risk patients).
✅ 28 Feb 2025 - Pacific Edge / Cxbladder announcement: Cxbladder Triage is specifically named in the AUA microhematuria amendment and described as the urine biomarker with highest supporting evidence ("Grade A" in the guideline context).
✅ 29 Apr 2025 - AUA 2025 plenary/conference reports: real-world evaluations (Kaiser Permanente and others) and presentations showing Cxbladder Triage/Triage Plus utility in triaging hematuria patients - strengthens clinical uptake of urine-based diagnostics to reduce unnecessary cystoscopy.
✅ 24 Mar 2025 - EAU 2025 highlights: EpiCheck-triggered photodynamic diagnosis and other enhanced cystoscopy adjuncts were presented as methods that detect high-grade recurrences missed by standard white-light cystoscopy - relevant to hematuria diagnostic pathways.
✅ 9 Apr 2025 - Growth-equity activity: General Atlantic makes a growth investment in U.S. Urology Partners (strengthening practice consolidation / MSO networks that influence referral patterns and service delivery for hematuria evaluation).
✅ (Apr-Jun 2025) Diagnostics & imaging vendor momentum: multiple vendors showcased upgraded cystoscopy/ureteroscopy imaging systems and noninvasive urine-test validation data across conferences in 2025 industry push to de-intensify invasive hematuria workups where appropriate.
✅ 12 Aug 2025 - (major MSO deal affecting urology care consolidation) Cardinal Health announced agreement to acquire Solaris Health (a large urology MSO) - transaction expands multi-specialty/MSO footprints that will affect urology service networks and hematuria care delivery.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/hematuria-treatment-market?sg
Key market growth drivers:
✅ Rising prevalence of urological disorders & ageing populations - growing incidence of bladder cancer, recurrent UTIs, kidney stones and age-related urologic conditions increases demand for hematuria diagnosis and treatment.
✅ Improved diagnostics and minimally invasive therapies - wider adoption of cystoscopy (including single-use cystoscopes), advanced imaging and endoscopic treatments raises diagnosis rates and expands treatment pathways.
✅ Greater awareness and screening / earlier detection - screening programs and guideline-driven evaluation of microscopic/macroscopic hematuria lead to more investigations and downstream treatment interventions.
✅ R&D, pipeline activity and device innovation - investment in urology devices, disposable/endoscopic tools and therapeutic pipelines supports market expansion and creates new commercial opportunities.
Regional share & dynamics:
➠ North America - largest share (~~35-40%): The United States leads because of advanced healthcare infrastructure, high healthcare spend, established urology centers and broad adoption of diagnostic/therapeutic technologies. Several market reports identify North America as the dominant regional market.
➠ Europe - second largest: Strong clinical research activity, reimbursement coverage and demand for novel therapies keep Europe as a major market (notably Germany, UK, France).
➠ Asia-Pacific - fastest-growing: Higher unmet need, expanding healthcare access, rising disease burden and investments in diagnostics make APAC the fastest-growing region (China and India singled out by several sources).
Segments Covered in the Hematuria Treatment Market:
By Type (Drugs, Therapies)
By Disease Type (Microscopic Hematuria, Gross Hematuria)
By End-User (Hospitals, Specialty Clinics, Other)
Regional Analysis for Hematuria Treatment Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=hematuria-treatment-market?sg
Major Key Players: Johnson & Johnson, Cipla Ltd., Hoffmann La Roche Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co., Pfizer Inc., Aurobindo Pharma USA, Zambon USA Ltd., GlaxoSmithKline plc.
Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription?sg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hematuria Treatment Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Johnson & Johnson, Cipla Ltd, Pfizer Inc., Aurobindo Pharma USA, Zambon USA Ltd., GlaxoSmithKline plc here
News-ID: 4285290 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Induction Motor Market 2031 | Growth Drivers, Trends & Market Fore …
Induction Motor Market size was worth US$ 20.36 billion in 2023 and is estimated to reach US$ 33.66 billion by 2031, growing at a CAGR of 6.49% during the forecast period (2024-2031).
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/induction-motor-market?kb
List of Top Key Player:
ABB Ltd., Ametek, Emerson Electric, Siemens AG, Brook Crompton, Danaher Corporation, Johnson Electric Holdings, Regal Beloit, WEG Electric Corp.…
Digital Therapeutics Market Set for Explosive Growth to USD 39.52 Billion by 203 …
The Global Digital Therapeutics Market size reached USD 6.84 billion in 2024 and is expected to reach USD 39.52 billion by 2033, growing at a CAGR of 21.6% during the forecast period 2025-2033.
Market growth is driven by the rising prevalence of chronic diseases like diabetes and mental health disorders, increasing smartphone penetration, and growing patient demand for personalized, app-based interventions. Advancements in AI and machine learning for behavior change, expanding…
United States Contrast Media Injectors Market: Real-Time Market Trends & Competi …
DataM Intelligence unveils its latest report on the "Contrast Media Injectors Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies…
United States Real Time Location System (RTLS) Market Analysis 2026: Growth Driv …
Real Time Location System (RTLS) Market is expected to grow at a CAGR of 18% during the forecasting period (2022-2029).
Request a Premium Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://www.datamintelligence.com/download-sample/real-time-location-system-market?kb
United States: Recent Industry Developments
✅ December 2025: Major healthcare systems expanded RTLS deployments to enhance patient tracking, asset utilization, and workflow efficiency.
✅ November 2025: Leading tech providers integrated AI‐driven analytics into RTLS platforms to deliver predictive…
More Releases for Hematuria
The Hidden Goldmine: Exploring the Untapped Hematuria Treatment Market
The Hematuria Treatment Market sector is undergoing significant transformation, with substantial growth and technological advancements expected by 2031. According to a new in-depth market research report, the sector is poised for expansion, driven by various factors such as market size, share, and emerging trends.
This comprehensive report provides key insights into the Hematuria Treatment market, exploring critical market segmentation and definitions. It highlights the essential components driving growth, offering a clear…
Hematuria Treatment Market Global Rising Demand & Huge Scope Till 2031
Hematuria Treatment Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.…
Hematuria Treatment Market Growth, Future Prospects And Competitive Analysis (20 …
The Hematuria Treatment Market is projected to reach US$ 1,103.61 million by 2028 from US$ 932.89 million in 2021; it is estimated to grow at a CAGR of 2.4% from 2020 to 2028.
Factors such as the high prevalence of hematuria-associated indications, and increasing awareness about treatment options and improving healthcare expenditure are driving the market growth. However, the undiagnosed cases of associated indications affect the effectiveness of hematuria treatments, thereby…
Hematuria Market Size, Epidemiology, Analysis & Trends 2023-2033
Hematuria Market Report Overview:
Report Attribute Details
Base Year …
Hematuria Treatment Market Insight And Comprehensive Analysis By 2028
Hematuria Treatment Market research study 2022-2028 enhances the decision-making capabilities and helps to create potent counter strategies to obtain competitive advantage says a latest research report at the insight partners. Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Request sample pages of this research study at-
https://www.theinsightpartners.com/sample/TIPRE00004601/?utm_source=OpenPR&utm_medium=10366
The hematuria treatment market is projected to reach US$ 1,103.61 million by 2028 from US$…
Hematuria Treatment Market Overview, Application and Geographical Segmentation 2 …
Market Highlights
The Global Hematuria treatment market has been examined as a growing market and expected to develop at a tremendous rate. There is huge demand for Hematuria treatment in North American countries like US and Canada. Growing incidence rate of various types of Hematuria and increasing number of traumatic injury cases are some of the factors driving the growth of the market. Further factors such as the risks involved in…
